Oligodendrocyte progenitor cell replacement (OPC)

Oligodendrocyte progenitor cells are a type of glial cell found throughout the central nervous system, serving as the precursors to myelinating oligodendrocytes. They are essential for normal development, maintenance, and repair of myelin, and play a key role in remyelination after injury or in diseases such as multiple sclerosis. Therapeutic strategies described as "oligodendrocyte progenitor cell replacement" involve the engraftment or transplantation of OPCs—derived from pluripotent stem cells or reprogrammed cells—to restore myelination where it has been lost. While OPCs are not a traditional molecular drug target like a receptor or enzyme, they represent a promising cell-based target for regenerative medicine in demyelinating disorders.

Other names

oligodendrocyte precursor cellNG2-gliaO2A cellpolydendrocyte

Promotion of oligodendrocyte differentiation for remyelination; Modulation of signaling pathways (e.g., PDGF, muscarinic receptors)